Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older and have been diagnosed with breast cancer (any gender)
- You have early-stage breast cancer of any type, or in some cases, breast cancer that has come back only in the local or nearby area and can still be treated with the goal of cure
- You are about to start chemotherapy before surgery (neoadjuvant chemotherapy), OR you have recently finished that chemotherapy before surgery and did not have a complete response to it, OR you have already had surgery and are currently receiving or planning to receive standard follow-up chemotherapy and meet certain additional medical criteria (confirm with trial site)
- You are willing to provide a recent tissue sample from your tumour (a fresh sample is preferred but may not always be required)
- You are able to understand and sign a consent form agreeing to take part
Who may not be able to join:
- You have not signed, or have withdrawn from, the consent form for the trial
- It is not possible to obtain a tissue sample from your tumour for testing
- You have a physical or mental condition, or a serious other health problem, that would make it difficult to participate properly in the trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comprehensive assessment of clinical patient data, collection of biomaterial and implementation of genomics- / molecular- and immune- guided precision medicine in eBC into the clinics.; Setting up a clinical and multidimensional, molecular diagnostic registry platform for patients with eBC and high risk for relapse.; Assessment of feasibility and retrieval of the logistical, clinical and information basis to screen and enroll patients for independent molecular-driven intervention trials (independent of this registry, e.g. COGNITION-GUIDE).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.